Disclosures for "Psilocybin’s Effects on Headache Frequency are Not Related to Acute Psychedelic Effects or Measures of Mental Health: Secondary Analysis of Clinical Trials in Migraine and Cluster Headache"
-
Dr. Schindler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. The institution of Dr. Schindler has received research support from National Headache Foundation. Dr. Schindler has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Gottschalk has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Gottschalk has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Gottschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Gottschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Gottschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spherix Global Insights. Dr. Gottschalk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Gottschalk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tonix. Dr. Gottschalk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Impel. Dr. Gottschalk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vectura Fertin. Dr. Gottschalk has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Northeast (HCNE). The institution of Dr. Gottschalk has received research support from Rehaler.
-
Prof. DSouza has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atai. Prof. DSouza has received personal compensation in the range of $0-$499 for serving as a Consultant for Inverready. Prof. DSouza has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for France Foundation. Prof. DSouza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Northwell. Prof. DSouza has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for France Foundation. Prof. DSouza has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Psychopharmacology. The institution of Prof. DSouza has received research support from Boehringer Ingelheim. The institution of Prof. DSouza has received research support from NIDA. The institution of Prof. DSouza has received research support from VA CS&RD. The institution of Prof. DSouza has received research support from Wallace Research. The institution of Prof. DSouza has received research support from Takeda. Prof. DSouza has received research support from Cerevel. Prof. DSouza has received publishing royalties from a publication relating to health care.